Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes

    ... risks associated with transfusions, chronic anemia and red blood cell (RBC) transfusion dependence impact negatively on survival and ...

    Research Article last updated 06/15/2012 - 2:03pm.

  2. Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?

    ... Erythropoiesis-stimulating agents (ESA) may reduce red blood cell transfusion requirements. MDS patients receiving ESA were ...

    Research Article last updated 12/09/2015 - 8:52am.

  3. Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes

    ... Overall Response (complete or partial remission, red blood cell [RBC] or platelet transfusion independence [TI], or ...

    Research Article last updated 12/09/2015 - 8:56am.

  4. Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

    ... the response is variable and some patients remain red blood cell transfusion -dependent. In 72 patients with hemolytic Paroxysmal ...

    Research Article last updated 09/26/2013 - 3:28pm.

  5. Eltrombopag Added to IST Yields Encouraging Results

    ... improvement in platelet counts but also noticed recovering red and white blood cells numbers. Although the magnitude of the response was somewhat ...

    Interview last updated 05/24/2017 - 7:44am.

  6. AAMDSIF Summer Fellowship Grant Program

    ... (BM) characterized by profound decrease of the number of red blood cells, white blood cells, and platelets in the blood stream, leading to ...

    Page last updated 05/17/2017 - 1:29pm.

  7. The immunomodulatory agents lenalidomide and thalidomide for treatment of the myelodysplastic syndromes: A clinical practice guideline.

    ... expected with the aging population. Treatment includes red blood cell transfusion for anemia . The immunomodulatory agents ...

    Research Article last updated 10/01/2012 - 10:04am.

  8. Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes

    ... that lenalidomide is effective not only in reducing red blood cell (RBC) transfusion burden, but also in modifying the disease ...

    Research Article last updated 12/08/2015 - 1:06pm.

  9. Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

    Journal Title:  Blood Primary Author:  Peffault ... During the study, six patients received at least one red blood cell transfusion . Lack of detectable CH50 activity (defined by ...

    Research Article last updated 01/20/2015 - 2:28pm.

  10. Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

    ... dependency (defined as having received at least one red blood cell transfusion every 8 weeks over a period of 4 months), Eastern ...

    Research Article last updated 11/10/2015 - 10:47am.